B.C. limits sales of two more diabetes drugs amid off-label use for weight loss
The limits on sales of Type 2 diabetes drugs tirzepatide and dulaglutide come after a 2023 regulation limited sales of semaglutide, which is sold under the band name Ozempic.
The rules mean B.C. pharmacists will not be able to sell the drugs to people who are not citizens or permanent residents of Canada and are not at the pharmacy in person.
Health Minister Josie Osborne says the drugs' use for weight loss is driving shortages in several countries, including the United States.
She says the province is working to ensure people living with diabetes have access to the medications they need, although non-residents and foreign citizens with a valid Canadian prescription can still buy them in person.
Tirzepatide and dulaglutide are commonly sold under the brand names Mounjaro and Trulicity.
Wednesdays
Columnist Jen Zoratti looks at what's next in arts, life and pop culture.
The ministry says the College of Pharmacists of B.C. is responsible for ensuring that college registrants comply with the regulation.
This report by The Canadian Press was first published July 17, 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
an hour ago
- CTV News
B.C. health minister apologizes to family of 10-year-old girl with rare disease
Charleigh Pollock and her mother Jari Fales. Charleigh's parents have been told her expensive treatment for a rare neurological disease will no longer be funded by the B.C. government. British Columbia Health Minister Josie Osborne is 'sincerely apologizing' to the family of a 10-year-old girl on Vancouver Island with a rare disease after a public fight over the province's decision to cut off paying for her medication. Osborne issued the apology at a news conference after her government announced it would restore the drug funding for Charleigh Pollock, the only person in B.C. with Batten Disease. The province cut off funding last month for the drug called Brineura — which costs about $1 million per year — citing an expert committee, which said the drug was no longer helping to slow the progress of the girl's disease. But Osborne personally called Pollock's mother Jori Foles Thursday to tell her that government would restore funding, citing another group of experts. Osborne says Pollock should not be suffering because of 'significant disagreement' among experts. Pollock's mother Jori Fales celebrated in a video posted on social media, saying the 'nightmare is over,' adding she is 'beyond grateful' to supporters who backed her cause to have the funding restored. This report by Wolfgang Depner, The Canadian Press, was first published July 18, 2025.
Winnipeg Free Press
2 hours ago
- Winnipeg Free Press
Mother of girl with rare disease says 'nightmare is over' after B.C. restores funding
VICTORIA – The mother of a 10-year-old Vancouver Island girl who has an extremely rare disease says the 'nightmare is over' after the government restored funding for her daughter's drug for as long as she needs it. Charleigh Pollock is the only person in B.C. to have Batten disease, and her mother Jori Fales says in a social post that she is 'beyond grateful' for 'all the beautiful humans that have moved mountains' for her daughter. Pollock says the 'love, support, generosity, compassion, kindness and devotion' shown by supporters of her daughters are 'unmatched.' Health Minister Josie Osborne announced on Thursday that the government has restored funding for the drug Brineura, which costs about $1 million per year. Government had cut off funding last month, citing an expert committee that said the drug was no longer helping to slow the progress of the girl's disease. Premier David Eby acknowledged on Thursday that a letter from a different group of experts in the United States had raised concern about the decision, and Osborne said the girl and her family should not suffer because of a 'significant disagreement' among experts. This report by The Canadian Press was first published July 18, 2025.
Vancouver Sun
4 hours ago
- Vancouver Sun
B.C. Health Ministry restores drug funding for girl with rare disease
British Columbia's Health Minister Josie Osborne says she has reinstated funding for a nine-year-old girl who has an extremely rare disease. Charleigh Pollock has Batten disease, and the drug Brineura costs around $1 million a year. Osborne says she spoke with the girl's family tonight and told them that the funding would be available 'for as long as the treating physician and the family deem it appropriate.' Osborne says she believes health professionals should make decisions about care, and a letter she received from Batten disease experts in the United States detailed a 'significant disagreement.' Start your day with a roundup of B.C.-focused news and opinion. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Sunrise will soon be in your inbox. Please try again Interested in more newsletters? Browse here. The minister says the Vancouver Island girl and her family should not suffer because of the disagreement over the drug. The government had cut off the funding last month, saying an expert committee determined that the drug was no longer helping to slow the progress of the girl's disease. Pollock is the only person in B.C. to have the disease and one of about 20 in Canada. This report by The Canadian Press was first published July 17, 2025. Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here .
